Article (Scientific journals)
Bone forming agents for the management of osteoporosis
Reginster, Jean-Yves; NEUPREZ, Audrey; Beaudart, Charlotte et al.
2014In Panminerva Medica, 56 (2), p. 97-114
Peer Reviewed verified by ORBi
 

Files


Full Text
Panminerva Med-2933_Manuscript (PDF)_V1_2014-02-24.pdf
Publisher postprint (514.56 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Osteoporotic fractures are a major cause of morbidity in the population. Anti-resorptive agents have been, for more than 15 years, the mainstay of osteoporosis treatment worldwide. However, these medications provide only limited fracture reduction and may be linked to skeletal and non-skeletal long-term safety concerns. Therefore, some patients are considered candidates for bone-forming agents because they remain severely osteoporotic or because they failed antiresorptive therapy. Over the last decade, a particular interest was shown in the developmentofmedicationsabletoincreaseosteoblastsnumber,lifespan or activity, hence stimulating bone formation Peptides from the parathyroid hormone family and strontium ranelate were shown to significantly reduce fracture rates but strontium ranelate is no longer an option for treating osteoporosis because of its safety profile. New therapeutic options, including monoclonal antibodies against sclerostin seem to be promising but their role in the armamentarium of osteoporosis will depend on the results of the current phase 3 studies, assessing antifracture efficacy and long-term safety.
Disciplines :
General & internal medicine
Author, co-author :
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
NEUPREZ, Audrey ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Beaudart, Charlotte ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Buckinx, Fanny  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Slomian, Justine ;  Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie clinique
Distèche, Stéphan ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Bone forming agents for the management of osteoporosis
Publication date :
2014
Journal title :
Panminerva Medica
ISSN :
0031-0808
eISSN :
1827-1898
Publisher :
Edizioni Minerva Medica, Italy
Volume :
56
Issue :
2
Pages :
97-114
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 20 March 2014

Statistics


Number of views
53 (14 by ULiège)
Number of downloads
3 (3 by ULiège)

Scopus citations®
 
2
Scopus citations®
without self-citations
1

Bibliography


Similar publications



Contact ORBi